SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY

SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY

Bibliographic Details
Main Authors: M.M.O. Barros, A. Röth, W. Barcellini, T.H.A. Tvedt, Y. Miyakawa, D.J. Kuter, W. Hobbs, J. Su, X. Jiang, J.M. Arias, I.C. Weitz
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137920303813

Internet

http://www.sciencedirect.com/science/article/pii/S2531137920303813

Similar Items